Christopher Perez
Internal Medicine · Galveston, TXNPI 1932635851
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (40.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Abbott at 59.2% of the total. 2025 is the largest year on record at $13,955, more than ten times the $244 reported in 2021. Among internal medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $167.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$20K
- Boston Scientific$7K
- Medtronic$4K
- Biosense Webster, Inc.$993
- Abiomed$553
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$351
- plus $1K from 12 others
What the payments were for
- Grants$13,64140%
- Travel & lodging$9,35027%
- Food & beverage$9,89829%
- Education$1,1193%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 72 | $20,118 |
| Boston Scientific | 34 | $6,746 |
| Medtronic | 42 | $4,239 |
| Biosense Webster, Inc. | 12 | $993 |
| Abiomed | 15 | $553 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $351 |
| AstraZeneca | 3 | $156 |
| E.r. Squibb & Sons, L.L.C. | 3 | $151 |
| Lantheus Medical Imaging, Inc. | 2 | $139 |
| Novo Nordisk | 2 | $131 |
| Novartis | 3 | $104 |
| Merck | 2 | $102 |
| CMP Pharma, Inc. | 1 | $102 |
| Imperative Care, Inc | 1 | $42 |
| Aurinia Pharma U.S., Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $22 |
| Pfizer | 1 | $21 |
| Chiesi USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Farapulse$4,633
- ASSURITY$3,413
- GALLANT$1,752
- GENERAL - THERAPIES$1,340
- CARDIOMEMS$1,286
- TACTICATH$1,138
- Micra$896
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$676
- Carto 3$674
- ENSITE$562
- AVEIR$232
- EnSite Precision Cardiac Mapping System$227
- ADVISA DR MRI SURESCAN$178
- Impella$150
- ELIQUIS$127
- TEZSPIRE$122
- EMBLEM MRI S-ICD$117
- Definity$111
- AZURE XT DR MRI SURESCAN$107
- Carospir$102
How this compares
$34,008 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 24 | $609 |
| Carvedilol | 22 | $380 |
| Losartan Potassium | 12 | $338 |
| Lisinopril | 13 | $98 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Galveston
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
- Hussein TawbiHouston$365K
- Hans LeeHouston$327K
- Tapan KadiaHouston$311K
- Nitin JainHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.